Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
01 4BUPROPION HYDROCHLORIDE
02 1DESVENLAFAXINE SUCCINATE
03 1DICLOFENAC SODIUM
04 1GUAIFENESIN
05 1GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
06 3LEVETIRACETAM
07 3METFORMIN HYDROCHLORIDE
08 2METOPROLOL SUCCINATE
09 2NIACIN
10 1TRAMADOL HYDROCHLORIDE
01 175492
02 176250
03 176378
04 178783
05 191430
06 1202095
07 1202306
08 1202774
09 1202775
10 1203028
11 1203059
12 1203699
13 1203755
14 1204003
15 1206941
16 1209215
17 1210497
18 1211020
19 1213247
01 19No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : TRAMADOL HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 78783
Country : US
Patented : No
Drug : BUPROPION HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 210497
Country : US
Patented : No
Drug : METFORMIN HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 203755
Country : US
Patented : No
Drug : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 204003
Country : US
Patented : No
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Drug : GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 206941
Country : US
Patented : No
Drug : NIACIN
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 76378
Country : US
Patented : No
Drug : NIACIN
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 76250
Country : US
Patented : No
Drug : GUAIFENESIN
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 209215
Country : US
Patented : No
Drug : METFORMIN HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 202306
Country : US
Patented : No
Drug : BUPROPION HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 202774
Country : US
Patented : No
LOOKING FOR A SUPPLIER?
